New drugs may hold the key to melanoma treatment
By Catholic Online (NEWS CONSORTIUM)
6/3/2014 (3 years ago)
Catholic Online (www.catholic.org)
Two new drugs may provide an exciting and striking treatment option for those who suffer from advanced cases of melanoma.
Image scans of Steele's lungs before and after his treatment. The left scan shows numerous gray colored cancer tissues, which are gone in the right, after his treatment.
LOS ANGELES, CA (Catholic Online) - In separate international trials, new drugs pembrolizumab and nivolumab, have seen great success treating melanoma, which is the most dangerous type of skin cancer, and also causes the most amount of deaths of any skin disease. When melanoma spreads to other organs it is very difficult to treat, and, until a few years ago, average survival was around half a year.
Both drugs are designed to help the immune system recognize and target cancerous cells by blocking the biological pathway the cancers use to disguise themselves from the immune system.
Pembrolizumab, formerly known as MK-3475, was tested on 411 patients, of which 69% survived for at least one year. This drug is also being tested on cancers which utilize a similar method to block attacks from the immune system.
"Pembrolizumab looks like it has potential to be a paradigm shift for cancer therapy," said Dr. David Chao, consultant oncologist at the Royal Free London NHS Foundation Trust. Chao is conducting trials on melanoma and lung cancer patients.
64-year-old Warwick Steele has been receiving infusions of the drug every three weeks since October, and has seen phenomenal results.
"I got tired simply standing up and was literally too exhausted to shave. But now I feel back to normal and can do gardening and go shopping," he said.
Prior to his treatment, Steele could barely walk because the cancers in his lungs made it hard to breath. Scans have shown that just after three infusions, the cancer seems to have been totally cleared out of his lungs.
Nivolumab, which was tested in conjunction with the existing immunotherapy ipilimumab, saw 85% of its' 53 patients survive past a year, and 79% after two years.
Copyright 2017 - Distributed by THE CALIFORNIA NETWORK
Pope Francis Prayer Intentions for JUNE 2017
National Leaders. That national leaders may firmly commit themselves to ending the arms trade, which victimizes so many innocent people.
The bishops of the Church in the United States have sent a letter to all 100 senators, asking them to be mindful of their concerns when ... continue reading
Young Americans are dying at a rate not seen since the Vietnam War. Greenwich, Connecticut (CNA/EWTN News) - But they are not dying in ... continue reading
Belief in God may help people avoid type 2 diabetes, and help others with the disease to do better. The conclusion comes as a shock to ... continue reading
Ireland's Sisters of Charity will end their management of three Dublin hospitals, the sisters have announced, saying they will hand over ... continue reading
It's tough trying to figure out how to juggle school, kids, work, significant others, a social life and extra time to run to the gym, but ... continue reading
by Catholic Online
- 'Half-Man-Half-Beast sent by the Devil' sparks fear in South African ...
- St. William of Vercelli: Saint of the Day for Sunday, June 25, 2017
- Daily Reading for Monday, June 26th, 2017 HD Video
- The end of the farm as we know it has arrived - here's how we're ...
- Daily Reading for Tuesday, June 27th, 2017 HD Video
- Daily Readings for Sunday, June 25, 2017
- How a Catholic should deal with Tinder and other dating apps
- Daily Reading for Sunday, June 25th, 2017 HD
- Pope Francis prepares an incredible gift of love and solidarity for South Sudan HD
- St. Emma HD
- Daily Reading for Saturday, June 24th, 2017 HD